SUBSCRIBE TO TMCnet
TMCnet - World's Largest Communications and Technology Community
 
| More

TMCNet:  Glooko Hires Former Intuit Health Executive Rick Altinger as CEO and Epocrates Executive Dean Lucas as VP of Product Development, Receives FDA 510(k) Clearance

[January 17, 2013]

Glooko Hires Former Intuit Health Executive Rick Altinger as CEO and Epocrates Executive Dean Lucas as VP of Product Development, Receives FDA 510(k) Clearance

PALO ALTO, Calif., Jan 17, 2013 (PRWeb.com via COMTEX) -- Glooko, Inc., makers of an innovative mobile logbook solution for people with diabetes, today announces the hiring of Rick Altinger as CEO and Dean Lucas as vice president of product development. In addition to growing its team, the company received FDA 510(k) over-the-counter clearance for its products and launches Glooko Logbook Charts to allow people with diabetes to analyze blood glucose readings through visual graphs.


Rick Altinger will serve as Glooko's first CEO, and brings over 15 years of industry experience in healthcare information technologies. While an executive at Intuit Health, Altinger helped launch the healthcare division's provider services and drove Intuit's acquisition of Medfusion in 2010. He also spearheaded Intuit Health's growth as the leading supplier of patient-provider communication and patient portal services. His technical knowledge and expertise is central to Glooko's diabetes healthcare platform and its goal of allowing anyone to monitor blood glucose levels regardless of meter or mobile device type. Altinger fills the CEO role held previously on an interim basis by Glooko co-founder and chairman Yogen Dalal.

"Lack of support across multiple meter types and differing data transfer methods have long withheld a truly unified diabetes management solution," said Glooko CEO Rick Altinger. "Glooko has cracked this code and created a universal diabetes management platform, and I look forward to continued innovation and implementation of Glooko across healthcare as a unifying force in a disjointed ecosystem." Dean Lucas also joins the Glooko team as the vice president of product development. Lucas comes to Glooko with over 17 years of experience leading product design and engineering for web and mobile healthcare applications at both Doximity and Epocrates, where he oversaw user interface and product design for mobile healthcare technologies used by over a million healthcare professionals.

Previously only available to users in the European Union, today also marks the debut of Glooko Logbook Charts in the U.S., which gives people using Glooko Logbook a more in-depth analysis and visualization of blood glucose data through easy to read charts that can be shared with healthcare professionals. The charts can be displayed in three formats: chart by time of day, chart by date, and chart by analysis of time of day. These charting capabilities give users and their healthcare team a comprehensive way to compare blood glucose readings over time so they can view how different factors--from diet and exercise to medication and treatments--impact their readings.

Glooko's MeterSync Cable, Logbook app, and Logbook Charts are available in the United States with 510(k) over-the-counter clearance from the FDA.

"We are thrilled to have worked collaboratively with the FDA to validate our solution as a system capable of being used across the healthcare system," said Yogen Dalal, Glooko co-founder. "With Rick at the helm and Dean as VP of product development, we look forward to more product innovation that will continue to improve the way diabetes is managed." Glooko's MeterSync Cable and Logbook app provides people with a mobile and accurate platform for syncing blood glucose readings from their blood glucose meters. By simply connecting the MeterSync Cable to one of the 15 compatible blood glucose meters in the U.S. to an iOS device, users can quickly download all of their readings directly into the Logbook app with a single click. This eliminates user error and saves time versus alternatives that depend on manual entry or paper logbooks. The Glooko Logbook app is free and available for download in the iTunes App Store: http://itunes.apple.com/us/app/glooko-logbook-diabetes-take/id471942748 mt=8.

The Glooko Logbook Charts spreadsheet is free and available for download from: http://www.glooko.com/#charts.

To purchase the Glooko MeterSync Cable and Glooko IR Adapter and learn more about pricing, visit: http://www.glooko.com/purchase/logbook/.

About Glooko Glooko(TM) is an innovative Silicon Valley startup with a unique solution for people with diabetes. Glooko's products with FDA 510(k) over-the-counter clearance - the MeterSync Cable and Glooko Logbook app for iOS devices - enable people with diabetes to easily collect, view and share the information needed to help them successfully control their blood glucose readings. It has been hailed by users and industry influencers for its ease of use and ability to provide context to daily data collected by people with diabetes. The company was founded in 2010 by technologist Yogen Dalal and mobile and web app developer, Sundeep Madra. Endocrinologist Michael S. Greenfield, M.D., is chief medical officer. Many on the Glooko team including the founders have a personal connection to diabetes. Glooko is backed by several Silicon Valley innovators, including former Facebook, Apple and Cisco executives. Together they are committed to helping people with diabetes live their lives while effortlessly managing their diabetes.

For more information: http://www.glooko.com.

Read the full story at http://www.prweb.com/releases/2013/1/prweb10333459.htm PRWeb.com

[ Back To Cisco News 's Homepage ]

FREE eNEWSLETTER


Cisco NEWS


FEATURED WHITE PAPERS


FEATURED PODCASTS


Cisco RSS FEEDS







Technology Marketing Corporation

800 Connecticut Ave, 1st Floor East, Norwalk, CT 06854 USA
Ph: 800-243-6002, 203-852-6800
Fx: 203-866-3326

General comments: tmc@tmcnet.com.
Comments about this site: webmaster@tmcnet.com.

STAY CURRENT YOUR WAY

© 2014 Technology Marketing Corporation. All rights reserved | Privacy Policy